INNOVATIVE THERAPY FOR MULTIPLE SCLEROSIS
Multiple Sclerosis is a debilitating neurological disease that is thought to be caused by the destruction of the myelin sheaths (fatty protective insulation) around axons of the brain and spinal cord. Loss of myelin impacts the ability of these tissues to conduct signals and the inflammatory process can lead to scarring resulting in a broad range of symptoms. This myelin damage appears to be related primarily to an auto-immune dysfunction, but there also appear to be environmental and genetic factors involved. There is no known cure for the physical and cognitive defects associated with chronic Multiple Sclerosis. Many investigators are looking at using the regenerative therapies to mitigate the impact of Multiple Sclerosis on the nervous system.
Cells And Multiple Sclerosis
Until recently, it was believed that damage to the brain tissue was permanent. Our clinical research has shown that regenerative therapy with an application intravenously, or through a spinal tap, crosses the blood-brain barrier and copies neural cell activity.
This treatment leads to the replacement of damaged cells and the restoration of brain function in most cases. In fact, a growing number of reports indicate that adult cells have the ability to stimulate the generation of new neurons, oligo-dendrocytes, and astrocytes.
The Center For Regenerative Cell Medicine has developed a specific treatment protocol that attempts to utilize the immuno-regulatory and anti-inflammatory properties of fat cells. Special measures are taken to optimize transport of these cells across the blood-brain barrier to improve central nervous system uptake. This is all done as an outpatient and the surgical procedure takes approximately three hours.